Click on image to view larger version.

Figure 2 End Points in the Study Groups

Incidence of primary end point (left) (absolute increase of creatinine 0.5 mg/dl over baseline value within 5 days after the administration of the radiographic contrast medium). Incidence of secondary end point: relative increase of creatinine 25% over baseline value within 5 days (middle) and within 2 days (right) after contrast agent administration. NS = no significant difference.